Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia

International Journal of Drug Policy

Volumn 24, Issue 4, 2013, Pages 326-332

  Islam, M Mofizul ^a,b   Topp, Libby ^c   Conigrave, Katherine M ^b,d,e   White, Ann ^f   Haber, Paul S ^d,g   Day, Carolyn A ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f Redfern Harm Minimisation Clinic   (Australia)

^g SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

Author keywords

Harm reduction; Injecting drug users; Low threshold healthcare; Primary health care

Indexed keywords

BENZODIAZEPINE; PSYCHOTROPIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BLOODSTREAM INFECTION; FEMALE; GENERAL PRACTITIONER; HARM REDUCTION; HEALTH CARE ACCESS; HEALTH CARE NEED; HEALTH CENTER; HEALTH PROGRAM; HEPATITIS B; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEXUALLY TRANSMITTED DISEASE; VACCINATION;

HARM REDUCTION; INJECTING DRUG USERS; LOW-THRESHOLD HEALTHCARE; PRIMARY HEALTH CARE;

ADULT; AGE FACTORS; FEMALE; GENERAL PRACTITIONERS; HEALTH SERVICES ACCESSIBILITY; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE; NEEDLE-EXCHANGE PROGRAMS; NEW SOUTH WALES; PATIENT ACCEPTANCE OF HEALTH CARE; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84880514043     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2012.06.002     Document Type: Article

References (37)

1. Anand B.S., Currie S., Dieperink E., Bini E.J., Shen H., Ho S.B., et al. Alcohol use and treatment of hepatitis C virus: Results of a national multicenter study. Gastroenterology 2006, 130:1607-1616.
2. Australian Bureau of Statistics 2006 Census QuickStats: Australia 2006.
3. Australian Government Department of Health and Ageing (DOHA) Australian immunisation handbook 2008, Canberra. 9th ed.
4. Binswanger I.A., Takahashi T.A., Bradley K., Dellit T.H., Benton K.L., Merrill J.O. Drug users seeking emergency care for soft tissue infection at high risk for subsequent hospitalization and death. Journal of Studies on Alcohol and Drugs 2008, 69:924-932.
5. Cromie S.L., Jenkins P.L., Bowden D.S., Dudley F.J. Chronic heaptitis C: Effect of alcohol on hepatitic activity and viral titre. Journal of Hepatology 1996, 25:821-826.
6. Darke S., Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence 1997, 48:135-141.
7. Darke S., Ross J., Teesson M., Ali R., Cooke R., Ritter A., et al. Factors associated with 12 months continuous heroin abstinence: Findings from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment 2005, 28:255-263.
8. Darke S., Ross J., Teesson M., Lynskey M. Health service utilization and benzodiazepine use among heroin users: Findings from the Australian Treatment Outcome Study (ATOS). Addiction 2003, 98:1129-1135.
9. Day C., White B., Dore G.J., van Beek I., Rodgers C., Cunningham P., et al. Hepatitis B virus among injecting drug users in Sydney Australia: Prevalence, vaccination and knowledge of status. Drug and Alcohol Dependence 2010, 108:134-137.
10. Drumm R.D., McBride D.C., Metsch L., Neufeld M., Sawatsky A. I'm a health nut!, Street drug users' accounts of self-care strategies. Journal of Drug Issues 2005, 35:607-629.
11. French M.T., Fang H., Balsa A.I. Longitudinal analysis of changes in illicit drug use and health services utilization. Health Services Research 2010, (published online: 9 December).
12. Friedman E. Money isn't everything. Nonfinancial barriers to access. Journal of American Medical Association 1994, 271:1535-1538.
13. Galdas P.M., Cheater F., Marshall P. Men and health help-seeking behaviour: Literature review. Journal of Advanced Nursing 2005, 49:616-623.
14. Haber P.S., Demirkol A., Lange K., Murnion B. Management of injecting drug users admitted to hospital. Lancet 2009, 374:1284-1293.
15. Havard A., Teesson M., Darke S., Ross J. Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment 2006, 30:355-362.
16. Heinzerling K.G., Kral A.H., Flynn N.M., Anderson R.L., Scott A., Gilbert M.L., et al. Unmet need for recommended preventive health services among clients of California syringe exchange programs: Implications for quality improvement. Drug and Alcohol Dependence 2006, 81:167-178.
17. Islam M.M., Reid S.E., White A., Grummett S., Conigrave K.M., Haber P.S. Opportunistic and continuing health care for injecting drug users from a nurse-run needle syringe program-based primary health-care clinic. Drug & Alcohol Review 2012, 31:114-115. author reply 116-117.
18. Islam M.M., Topp L., Day C.A., Dawson A., Conigrave K.M. The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature. International Journal of Drug Policy 2012, 23:94-102.
19. Iversen J., Topp L., Maher L. Australian NSP Survey National Data Report 1995-2010 2011, The Kirby Institute, UNSW, Sydney, Available at: http://www.med.unsw.edu.au/NCHECRweb.nsf/resources/NSP_Complete2/$file/ANSPS.1995_2010-rev.pdf Accessed September 2011.
20. Kimber J., Mattick R.P., Kaldor J., van Beek I., Gilmour S., Rance J.A. Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. Drug & Alcohol Review 2008, 1-11.
21. Kratzmann M., Mitchell E., Ware J., Banach L., Ward J., Ryan J. Injecting drug use and associated harms among Aboriginal Australians 2011, Australian National Council on Drugs, Canberra. J. Stokes (Ed.).
22. McCoy C.B., Metsch L., Chitwood D.D., Miles C. Drug use and barriers to use of health care services. Substance Use & Misuse 2001, 36:789-806.
23. Morrison A., Elliott L., Gruer L. Injecting-related harm and treatment-seeking behaviour among injecting drug users. Addiction 1997, 92:1349-1352.
24. Myers B.J. Primary health care for people who inject drugs in low and middle income countries: A response to "The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users". International Journal of Drug Policy 2012, 23:105-106.
25. NCHECR Australian NSP Survey National Data Report 2005-2009 2010, National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Sydney.
26. Rees V., Saitz R., Horton N.J., Samet J. Association of alcohol consumption with HIV sex- and drug-risk behaviours among drug users. Journal of Substance Abuse Treatment 2001, 21:129-134.
27. Stein M. Medical consequences of substance use. Psychiatric Clinics of North America 1999, 22:351-370.
28. Stein M.D., Hanna L., Natarajan R., Clarke J., Marisi M., Sobota M., et al. Alcohol use patterns predict high-risk HIV behaviours among active injections drug users. Journal of Substance Abuse Treatment 2000, 18:359-363.
29. Strang J., McCambridge J., Best D., Beswick T., Bearn J., Rees S., et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: Follow up study. BMJ 2003, 326:959-960.
30. Topp L., Day C.A., Iversen J., Wand H., Maher L. Fifteen years of HIV surveillance among people who inject drugs: The Australian Needle and Syringe Program Survey 1995-2009. AIDS 2011, 25:835-842.
31. Topp L., Iversen J., Wand H., Day C., Kaldor J., Maher L. Representativeness of injecting drug users who participate in HIV surveillance: Results from Australia's Needle and Syringe Program Survey. Journal of Acquired Immune Deficiency Syndromes 2008, 47:632-638.
32. Vento S., Garofano T., Renzini C., Cainelli F., Casali F., Ghironzi G., et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. New England Journal of Medicine 1998, 338:286-290.
33. Warner-Smith M., Darke S., Lynskey M., Hall W. Heroin overdose: Causes and consequences. Addiction 2001, 96:1113-1125.
34. Watson B., Conigrave K.M., Wallace C., Whitfield J.B., Wurst F., Haber P.S. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. Drug and Alcohol Review 2007, 26:231-239.
35. Western Australian Network of Alcohol and Other Drug Agencies (WANADA) WANADA GP Access (pilot) project evaluation summary 2009, Available at: www.wanada.org.au/Download./72-GP-Access-Project-Evaluation.html.
36. White B., Day C., Maher L. Self reported risk behaviour among injecting drug users: Self versus assisted questionnaire completion. AIDS Care 2007, 19:441-447.
37. World Health Organization Management of common health problems of drug users 2009, Retrieved from: http://www.searo.who.int/en/Section10/Section18/Section356_4609.htm. New Delhi.